Dendritic cell-based immunotherapy for head and neck squamous cell carcinoma: advances and challenges

Dendritic cell-based immunotherapy for head and neck squamous cell carcinoma: advances and challenges

Head and neck squamous cell carcinoma (HNSCC) is a prevalent cancer with poor response to conventional treatments such as surgery, chemotherapy and radiotherapy. Immune checkpoint inhibitors (ICIs) have revolutionized the treatment of HNSCC, but many patients still exhibit poor responses due to insu...

Full description

Saved in:
Bibliographic Details
Main Authors: Wenyue Chen, Zhengqiang Li, Jin Tang, Shuguang Liu
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-05-01
Series:Frontiers in Immunology
Subjects:
head and neck squamous cell carcinoma
dendritic cell
immunotherapy
cancer vaccine
cell therapy
immune checkpoint inhibitors therapy
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2025.1573635/full
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items